{"id":"W4391503037","doi":"10.1002/j.1536-4801.2006.tb01893.x","title":"MAINTENANCE THERAPY WITH INFLIXIMAB EVERY 8 WEEKS IS SUPERIOR TO EVERY 12 WEEKS IN MAINTAINING RESPONSE AND REMISSION IN PEDIATRIC PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE","year":2006,"lang":"en","type":"article","venue":"Journal of Pediatric Gastroenterology and Nutrition","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hospital for Sick Children","funders":"Danone","keywords":"Medicine; Infliximab; Crohn's disease; Maintenance therapy; Internal medicine; Disease; Crohn disease; Gastroenterology; Surgery; Pediatrics; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001668955,0.000369974,0.001784146,0.0002474623,0.0001710929,0.0004739114,0.0004157259,0.000627936,0.0009988766],"category_scores_gemma":[0.00233067,0.0002421864,0.0009317261,0.0002888041,0.000419068,0.0006115116,0.0002723493,0.00118592,0.0001657885],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002761318,"about_ca_system_score_gemma":0.0004080035,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004477367,"about_ca_topic_score_gemma":0.001106362,"domain_scores_codex":[0.9991713,0.0004651243,0.00009313351,0.00008426712,0.0001082263,0.00007800677],"domain_scores_gemma":[0.998446,0.0004687604,0.000542513,0.00009370966,0.0000551187,0.0003939042],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6410724,0.008980717,0.05338877,0.001785418,0.002956724,0.0005561662,0.0004661899,0.001667863,0.01879149,0.0003111045,0.001754247,0.2682689],"study_design_scores_gemma":[0.266022,0.5506473,0.1700669,0.0004155565,0.002008832,0.001531403,0.0001865922,0.002296797,0.002499672,0.0002325551,0.004023552,0.00006896244],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9895983,0.009449667,0.0001575418,0.0001620067,0.00005141253,0.00007721034,0.00007679396,0.00002942038,0.0003977221],"genre_scores_gemma":[0.9956869,0.002825856,0.0005888906,0.0002456397,0.0001143835,0.00009579938,0.0002503319,0.0000071688,0.0001849163],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001784146,"threshold_uncertainty_score":0.008826435,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.004029820946413035,"score_gpt":0.2042116666541371,"score_spread":0.200181845707724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}